December 2012: False news regarding Promoters of FDC selling their stake and exiting FDC, April 2012: FDC receives its 1st Indian Biotech Patent for the Invention entitled “METHOD FOR DETERMINING THE POTENCY OF G-CSF”. October 2011: FDC receives prestigious Pharmexcil Patents National Award 2010-11 in the recognition of FDC's contribution to R & D in bulk drug category. FDC's Ophthalmic unit at Waluj receives UKMHRA approval (April 2011). FDC receives approval from UKMHRA (RMS) for Dorzolamide 2% w/v Eye Drop Solution and Dorzolamide 2% w/v & Timolol Maleate 0.5% w/v Eye Drop Solution under Decentralised Procedure (June 2011)
F reedom of choice- Wide spectrum of Therapeutic segments to choose from.
D edication to serve- Highest quality standards with latest technology at affordable prices.
C are for all- Always committed towards better healthcare solutions.


to the world of FDC

FDC Eyrdrop
FDC International